In terms of valuation, Summit Therapeutics Inc’s market capitalization stands at $14.03 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...

William Blair has recently initiated Elevation Oncology Inc (ELEV) stock to Outperform rating, as announced on January 3, 2025, according to Finviz. Earlier, on May 31, 2024, Piper Sandler had ...

Summit Therapeutics plc (NASDAQ:SMMT) shares, currently trading at $19.03, maintained its Buy rating and $44.00 price target ...

SunCar Technology Group Inc. ("SunCar" or the "Company") (Nasdaq: SDA), a leading innovator in cloud-based B2B auto services and auto e-insurance in China, today announced the appointment of Mr.